ViroStatics
Sassari, Sardegna, Italy
About ViroStatics
ViroStatics is a small pharmaceutical company that develops novel compounds for a multifaceted treatment of cancers and viral diseases, focusing on novel, selective, host cell kinase targeted inhibitors. The Company has developed a robust pipeline of proprietary compounds to distinguish themselves from the competition through their unique kinase selectivity, efficacy and safety profiles. The Team and Advisors combines scientific, business, legal, and technology expertise, spanning the entire process of drug development from translational science through preclinical and clinical drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $52.7K
- Funding stage: Seed
- Last round: Grant (Mar 2017)
- Website: virostatics.com
- Phone: +39 079 998639
Industries & Categories
Biotechnology, Medical, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/virostatics-2252115 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.